|
業務類別
|
Biotechnology |
|
業務概覽
|
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novelintegrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform. |
| 公司地址
| 331 Oyster Point Boulevard, South San Francisco, CA, USA, 94080 |
| 電話號碼
| +1 650 481-6770 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.pliantrx.com |
| 員工數量
| 49 |
| Dr. Keith Cummings, M.B.A.,M.D. |
Chief Financial Officer |
美元 503.88K |
22/04/2026 |
| Dr. Bernard Coulie, M.B.A.,M.D.,PhD |
Director, President and Chief Executive Officer |
美元 682.00K |
22/04/2026 |
| Ms. Lily Cheung |
Chief Human Resources Officer |
-- |
22/04/2026 |
| Ms. Minnie Kuo |
Chief Operating Officer |
美元 470.70K |
22/04/2026 |
|
|
| Dr. John T. Curnutte, M.D.,PhD |
Independent Director |
22/04/2026 |
| Dr. Bernard Coulie, M.B.A.,M.D.,PhD |
Director, President and Chief Executive Officer |
22/04/2026 |
| Dr. Katharine Knobil, M.D. |
Independent Director |
17/04/2026 |
| Mr. Steven E. Krognes, M.B.A. |
Independent Director |
22/04/2026 |
| Mr. Thomas A. McCourt |
Independent Director |
22/04/2026 |
| Mr. Darren S. Cline, M.B.A. |
Independent Director |
22/04/2026 |
| Dr. Suzanne L. Bruhn, PhD |
Independent Director |
17/04/2026 |
| Ms. Gayle A. Crowell |
Independent Director |
22/04/2026 |
| Mr. David E.I. Pyott, M.A.,M.B.A. |
Independent Director |
17/04/2026 |
| Dr. Hoyoung Huh,M.D.,PhD |
Non-Executive Chairman of the Board |
22/04/2026 |
|
|
|
|
